Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 21-30 of 39

Page
per page
  1. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: inhibitor of polybromo 1 and SMARCA4
      insoluble in H2O; ≥15.15 mg/mL
  2. Reversine
    A3760 Reversine
    Target: Aurora Kinases
    Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  3. BMS-911543
    A4152 BMS-911543
    Target: JAK
    Summary: JAK2 inhibitor,selective small molecule
      ≥43.3 mg/mL
  4. Remodelin
    B4887 Remodelin
    Target: NAT10
    Summary: NAT10 inhibitor
      ≥36.3 mg/mL
  5. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL
  6. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  7. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
  8. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL
  9. PFI-2
    B4875 PFI-2
     1 Citation
    Target: SETD7
    Summary: SETD7 methyltransferase inhibitor
      ≥50 mg/mL
  10. HPOB
    B4890 HPOB
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor, potent and selective
      ≥31.4 mg/mL

Items 21-30 of 39

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 2item
  2. Aurora Kinase 4item
  3. HDAC 9item
  4. Histone Acetyltransferases 2item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 4item
  7. HIF 2item
  8. JAK 5item
  9. PARP 3item
  10. Pim 2item
  11. Protein Ser/Thr Phosphatases 3item
  12. Sirtuin 2item
Reversibility
  1. Reversible 1 item
Target
  1. Histone Deacetylases (HDACs) 8item
  2. PI3K 1 item
  3. Aurora Kinases 4item
  4. EZH2 1 item
  5. Bromodomains 1 item
  6. FLT3 1 item
  7. MEK 1 item
  8. DOT1L 1 item
  9. Pim 2item
  10. Sir2-like Family Deacetylases (Sirtuins) 2item
  11. PP1 1 item
  12. PP2A 1 item
  13. Src 1 item
  14. STAT 1 item
  15. Hypoxia Inducible Factors (HIFs) 1 item
  16. JAK 5item
  17. p300 1 item
  18. TNKS 1 item
  19. Topoisomerases 1 item
  20. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  21. PARP 2item
  22. phosphatases 1 item
  23. NAT10 1 item
  24. SETD7 1 item
  25. Histone Demethylases 1 item
  26. Protein Arginine Methyltransferases 1 item
  27. PP4 1 item
  28. c-RET 1 item
  29. Protein polybromo-1 1 item
  30. SMARCA4 1 item
  31. SMARCA2 1 item
  32. Lck 1 item
Reported Experiments
  1. Animal Experiments 30item
  2. Cell Experiments 21item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Breast Cancer 7item
  3. Cancer 24item
  4. Cervical Cancer 1 item
  5. Colon Cancer 3item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Diabetes 1 item
  9. Epilepsy 1 item
  10. Glioblastoma 1 item
  11. Glioma 1 item
  12. Hepatic Cancer 1 item
  13. Hepatocellular Carcinoma 1 item
  14. Inflammatory Diseases 1 item
  15. Leukemia 2item
  16. Lung Cancer 1 item
  17. Lymphoma 2item
  18. Melanoma 1 item
  19. Mixed Lineage Leukemia 1 item
  20. Multiple Myeloma 2item
  21. Myelofibrosis 1 item
  22. Non-small Cell Lung Cancer 3item
  23. Ovarian Cancer 3item
  24. Pancreatic Cancer 2item
  25. Prostate Cancer 5item
  26. Renal Cell Carcinoma 1 item
  27. Rheumatoid Arthritis 1 item